Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation

Fertility and Sterility

Volumn 96, Issue 1, 2011, Pages

  Nayak, Shweta R ^a   Wakim, Anthony N ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

fertility preservation; GnRH agonist; random start IVF

Indexed keywords

CETRORELIX; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CANCER PATIENT; CASE REPORT; CONTROLLED OVARIAN HYPERSTIMULATION; CRYOPRESERVATION; EMBRYO; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONAL REGULATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; FEMALE; FERTILITY; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; RANDOM ALLOCATION; YOUNG ADULT;

EID: 79959866664     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.04.079     Document Type: Article

References (20)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 A Cancer J Clin 60 2010 277 300
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2008, National Cancer Institute. Bethesda, MD. Based on November 2010 SEER data submission, posted to the SEER web site, 2011. Available at: http://seer.cancer.gov/csr/1975-2008/. Last accessed May 16, 2011.
3. A.R. Baerwald, G.P. Adams, and R.A. Pierson Characterization of ovarian follicular wave dynamics in women Biol Reprod 69 2003 1022 1031
4. M. Von Wolff, C.J. Thaler, T. Frambach, C. Zeeb, B. Lawrenz, and R.M. Popovici Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Fertil Steril 92 2009 1360 1365
5. G.M. Bedoschi, F.O. de Albuquerque, R.A. Ferriani, and P.A. Navarro Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature J Assist Reprod Genet 27 2010 491 494
6. M. Sönmezer, I. Türküolu, U. Cokun, and K. Oktay Random Start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles Fertil Steril 95 2011 2125.e9
7. B. Acevedo, L. Jose Gomez-Palomares, E. Ricciarelli, and E.R. Hernández Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates Fertil Steril 86 2006 1682 1687 (Pubitemid 44781379)
8. R. Babayof, J.E. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, and M. Gal Serum inhibin A, VEGF and TNFa levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum Reprod 21 2006 1260 1265
9. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, and K. Diedrich Non supplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J Clin Endocrinol Metab 88 2003 4186 4192 (Pubitemid 37158033)
10. B.C. Fauser, D. De Jong, F. Olivennes, H. Warmsby, C.J. Tay, and J. Itskovitz-Eldor Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715 (Pubitemid 34158241)
11. A. Galindo, D. Bodri, J.J. Guillén, M. Colodrón, V. Vernaeve, and O. Coll Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial Gynecol Endocrinol 25 2009 60 66
12. P. Humaidan, H.E. Bredkjær, L. Westergaard, and C.Y. Andersen 1500 IU hCG secures a normal clinical pregnancy outcome in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist Fertil Steril 93 2010 847 854
13. P. Humaidan, H.E. Bredkjær, L. Bungum, M. Bungum, M.L. Grøndahl, and L. Westergaard GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220 (Pubitemid 40796107)
14. P. Humaidan, M. Bungum, and C.Y. Andersen Rescue of corpus luteum function with periovulatoryHCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod Biomed Online 13 2006 173 178 (Pubitemid 44207763)
15. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. Van Steirteghem, P. Devroey, and K. Diedrich A lower ongoing pregnancyn rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892 (Pubitemid 41508652)
16. M.A.B. Melo, C.E. Busso, J. Bellver, P. Alama, N. Garrido, and M. Meseguer A randomized, prospective, controlled, assessor-blind study, comparing triptorelin vs. rhCG as trigger oocyte maturation in oocyte donors Fertil Steril 88 Suppl 1 2007 34
17. C. Pirard, J. Donnez, and E. Loumaye GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study Hum Reprod 21 2006 1894 1900 (Pubitemid 44028266)
18. M.A. Youssef, F. Van der Veen, H.G. Al-Inany, G. Griesinger, M.H. Mochtar, and I. Aboulfoutouh Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles Cochrane Database Syst Rev 1 2011 CD008046
19. M. Melo, C.E. Busso, J. Bellver, P. Alama, N. Garrido, and M. Meseguer GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study Reprod Biomed Online 19 2009 486 492
20. T.M. Erb, W. Vitek, and A.N. Wakim Gonadotropin releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program Fertil Steril 93 2010 374 378